Anzeige
Mehr »
Login
Donnerstag, 05.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 08.05.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
08.05.Northern Data Group - Continued progress as a diversified HPC provider403Northern Data Group demonstrated progress made in Q124 alongside a capital markets day update, as it takes further steps in becoming a diversified high-performance computing (HPC) infrastructure solutions...
► Artikel lesen
08.05.Oryzon Genomics - Doubling down on clinical activity in 2024291Oryzon's Q124 results emphasised the company's focus on advancing and expanding its CNS and oncology pipelines, driven by its core assets, vafidemstat and iadademstat. Operating performance was in line...
► Artikel lesen
08.05.AVAX - Strong pipeline reaffirmed216AVAX's FY23 results highlight the group's progress domestically as the market improved, more than offsetting the weaker international performance at the top-line and EBITDA level. We have downgraded...
► Artikel lesen
08.05.MGI - Media and Games Invest - A strong start to the year362MGI's Q124 report shows an impressive 21% organic revenue uplift over Q123, with both good new client recruitment and higher spend from existing clients as corporate confidence rebuilds. With the market...
► Artikel lesen
08.05.Claranova - EBITDA improvement across all divisions638On relatively flat H124 revenue, Claranova grew adjusted EBITDA more than 50% year-on-year as the focus on profitability over growth started to deliver. With Avanquest's loss-making non-core business...
► Artikel lesen
08.05.IRLAB Therapeutics - MSRD agreement early validation for IRL757588The McQuade Center for Strategic Research and Development (MSRD) has signed an exclusive R&D collaboration for Irlab's pre-clinical candidate IRL757, following recent clearance by Swedish authorities...
► Artikel lesen